| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.31e-09 | 35 | 119 | 7 | GO:0015020 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGGT2 B4GALNT3 UGT2B28 UGT2B11 | 3.39e-07 | 153 | 119 | 9 | GO:0008194 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGGT2 B4GALNT3 UGT2B28 UGT2B11 | 4.91e-06 | 211 | 119 | 9 | GO:0016758 |
| GeneOntologyMolecularFunction | retinoic acid binding | 2.20e-05 | 28 | 119 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | amino acid sensor activity | 3.52e-05 | 2 | 119 | 2 | GO:0140785 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGGT2 B4GALNT3 UGT2B28 UGT2B11 | 5.77e-05 | 288 | 119 | 9 | GO:0016757 |
| GeneOntologyMolecularFunction | alkylglycerol kinase activity | 1.05e-04 | 3 | 119 | 2 | GO:0047649 | |
| GeneOntologyMolecularFunction | protein binding involved in heterotypic cell-cell adhesion | 1.58e-04 | 18 | 119 | 3 | GO:0086080 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.91e-04 | 48 | 119 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.07e-04 | 49 | 119 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | RPL24 FLNB ILK PSEN1 NRCAM SIRPB1 SIRPA ADAMTS8 SVEP1 TENM4 TBC1D10A | 9.13e-04 | 599 | 119 | 11 | GO:0050839 |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 1.11e-03 | 76 | 119 | 4 | GO:0098631 | |
| GeneOntologyMolecularFunction | retinyl-palmitate esterase activity | 1.23e-03 | 9 | 119 | 2 | GO:0050253 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 1.60e-15 | 8 | 121 | 7 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 2.37e-14 | 10 | 121 | 7 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.55e-13 | 12 | 121 | 7 | GO:0052697 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 2.18e-11 | 21 | 121 | 7 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.20e-10 | 26 | 121 | 7 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.20e-10 | 26 | 121 | 7 | GO:0006063 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 1.79e-09 | 37 | 121 | 7 | GO:0042537 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.79e-09 | 37 | 121 | 7 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 2.18e-09 | 38 | 121 | 7 | GO:0008209 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.16e-08 | 52 | 121 | 7 | GO:0008210 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | RELN PNLIP CEL ACE UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 9.95e-07 | 286 | 121 | 11 | GO:0042445 |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.98e-05 | 141 | 121 | 7 | GO:0006805 | |
| GeneOntologyBiologicalProcess | cellular response to leucine starvation | 4.17e-05 | 12 | 121 | 3 | GO:1990253 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-12 | 5.40e-05 | 13 | 121 | 3 | GO:0071349 | |
| GeneOntologyBiologicalProcess | response to interleukin-12 | 1.04e-04 | 16 | 121 | 3 | GO:0070671 | |
| GeneOntologyBiologicalProcess | negative regulation of I-kappaB phosphorylation | 2.03e-04 | 4 | 121 | 2 | GO:1903720 | |
| GeneOntologyBiologicalProcess | negative regulation of macrophage inflammatory protein 1 alpha production | 3.37e-04 | 5 | 121 | 2 | GO:0071641 | |
| GeneOntologyBiologicalProcess | regulation of COPII vesicle coating | 3.37e-04 | 5 | 121 | 2 | GO:0003400 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 3.40e-04 | 222 | 121 | 7 | GO:0071466 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | NR0B1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 KIT | 3.80e-04 | 376 | 121 | 9 | GO:0008202 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular transport | 3.91e-04 | 162 | 121 | 6 | GO:0032388 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 8.00e-11 | 40 | 124 | 8 | GO:0005640 | |
| GeneOntologyCellularComponent | organelle outer membrane | PSEN1 ABCB6 PPP2R2B UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MTARC1 | 8.76e-07 | 279 | 124 | 11 | GO:0031968 |
| GeneOntologyCellularComponent | outer membrane | PSEN1 ABCB6 PPP2R2B UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MTARC1 | 9.40e-07 | 281 | 124 | 11 | GO:0019867 |
| GeneOntologyCellularComponent | nuclear membrane | PSEN1 TOR1A UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 NUP153 | 4.48e-05 | 349 | 124 | 10 | GO:0031965 |
| GeneOntologyCellularComponent | nuclear envelope | ABCF1 PSEN1 TOR1A XPO4 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 NUP153 | 1.27e-04 | 560 | 124 | 12 | GO:0005635 |
| GeneOntologyCellularComponent | organelle envelope | SLC25A41 ABCF1 PSEN1 MRS2 TOR1A XPO4 ABCB6 MRPS18A PPP2R2B SLC25A38 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 HERC2 UGT2B11 NUP153 MTARC1 | 2.94e-04 | 1435 | 124 | 20 | GO:0031967 |
| GeneOntologyCellularComponent | sperm midpiece | 5.69e-04 | 64 | 124 | 4 | GO:0097225 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | PSEN1 PTCHD3 TOR1A ABCB6 SEC22A SAR1A VKORC1L1 SAR1B ASPH UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 SLC33A1 NUP153 | 8.35e-04 | 1327 | 124 | 18 | GO:0042175 |
| GeneOntologyCellularComponent | TORC2 complex | 1.22e-03 | 9 | 124 | 2 | GO:0031932 | |
| Domain | UDPGT | 3.21e-11 | 21 | 116 | 7 | PF00201 | |
| Domain | UDPGT | 3.21e-11 | 21 | 116 | 7 | PS00375 | |
| Domain | UDP_glucos_trans | 3.21e-11 | 21 | 116 | 7 | IPR002213 | |
| Domain | SAR1 | 3.82e-05 | 2 | 116 | 2 | PS51422 | |
| Domain | Small_GTPase_SAR1 | 3.82e-05 | 2 | 116 | 2 | IPR006687 | |
| Domain | IGv | 1.03e-04 | 75 | 116 | 5 | SM00406 | |
| Domain | - | 1.14e-04 | 3 | 116 | 2 | 3.90.182.10 | |
| Domain | PA14 | 1.14e-04 | 3 | 116 | 2 | SM00758 | |
| Domain | PA14 | 1.14e-04 | 3 | 116 | 2 | PF07691 | |
| Domain | PA14_dom | 1.14e-04 | 3 | 116 | 2 | IPR011658 | |
| Domain | Na/ntran_symport_orphan | 3.78e-04 | 5 | 116 | 2 | IPR002438 | |
| Domain | Ig-like_fold | HSPG2 IL12RB2 ICOSLG FLNB NRCAM VSIG4 SIRPB1 SIRPA PKHD1L1 TGM5 BTNL3 IL1RAP KIT | 4.42e-04 | 706 | 116 | 13 | IPR013783 |
| Domain | - | HSPG2 IL12RB2 FLNB NRCAM VSIG4 SIRPB1 SIRPA PKHD1L1 TGM5 BTNL3 IL1RAP KIT | 8.59e-04 | 663 | 116 | 12 | 2.60.40.10 |
| Domain | V-set | 1.02e-03 | 184 | 116 | 6 | PF07686 | |
| Domain | IG | 1.26e-03 | 421 | 116 | 9 | SM00409 | |
| Domain | Ig_sub | 1.26e-03 | 421 | 116 | 9 | IPR003599 | |
| Domain | Ig_V-set | 1.53e-03 | 199 | 116 | 6 | IPR013106 | |
| Domain | DAGK_acc | 1.67e-03 | 10 | 116 | 2 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 1.67e-03 | 10 | 116 | 2 | IPR000756 | |
| Domain | DAGKa | 1.67e-03 | 10 | 116 | 2 | SM00045 | |
| Domain | DAGKc | 3.31e-03 | 14 | 116 | 2 | SM00046 | |
| Domain | IG_LIKE | 3.55e-03 | 491 | 116 | 9 | PS50835 | |
| Domain | Diacylglycerol_kinase_cat_dom | 3.81e-03 | 15 | 116 | 2 | IPR001206 | |
| Domain | DAGK | 3.81e-03 | 15 | 116 | 2 | PS50146 | |
| Domain | DAGK_cat | 3.81e-03 | 15 | 116 | 2 | PF00781 | |
| Domain | Ig-like_dom | 4.15e-03 | 503 | 116 | 9 | IPR007110 | |
| Domain | Nicotinic_acetylcholine_rcpt | 4.34e-03 | 16 | 116 | 2 | IPR002394 | |
| Domain | NAD/diacylglycerol_kinase | 4.89e-03 | 17 | 116 | 2 | IPR016064 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 5.48e-03 | 18 | 116 | 2 | PS00754 | |
| Domain | ZF_ZZ_2 | 5.48e-03 | 18 | 116 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 5.48e-03 | 18 | 116 | 2 | PS01357 | |
| Domain | ZZ | 5.48e-03 | 18 | 116 | 2 | PF00569 | |
| Domain | SNF | 6.10e-03 | 19 | 116 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 6.10e-03 | 19 | 116 | 2 | IPR000175 | |
| Domain | Znf_ZZ | 6.10e-03 | 19 | 116 | 2 | IPR000433 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 6.10e-03 | 19 | 116 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 6.10e-03 | 19 | 116 | 2 | PS50267 | |
| Domain | ZnF_ZZ | 6.10e-03 | 19 | 116 | 2 | SM00291 | |
| Domain | EGF_extracell | 6.18e-03 | 60 | 116 | 3 | IPR013111 | |
| Domain | EGF_2 | 6.18e-03 | 60 | 116 | 3 | PF07974 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.13e-10 | 23 | 95 | 7 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.59e-10 | 24 | 95 | 7 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.20e-10 | 25 | 95 | 7 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 2.20e-10 | 25 | 95 | 7 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 2.20e-10 | 25 | 95 | 7 | M605 | |
| Pathway | WP_GLUCURONIDATION | 2.99e-10 | 26 | 95 | 7 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 5.32e-10 | 28 | 95 | 7 | M19580 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 6.51e-09 | 39 | 95 | 7 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 9.41e-09 | 41 | 95 | 7 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.58e-08 | 44 | 95 | 7 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.86e-08 | 45 | 95 | 7 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 4.59e-08 | 51 | 95 | 7 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 5.27e-08 | 52 | 95 | 7 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 7.87e-08 | 55 | 95 | 7 | M14933 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.29e-07 | 64 | 95 | 7 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 4.28e-07 | 70 | 95 | 7 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 5.20e-07 | 72 | 95 | 7 | M9257 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 7.61e-06 | 107 | 95 | 7 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 8.60e-06 | 109 | 95 | 7 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 8.60e-06 | 109 | 95 | 7 | M18788 | |
| Pathway | REACTOME_DRUG_ADME | 1.53e-05 | 119 | 95 | 7 | MM15692 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MTARC1 | 1.14e-04 | 219 | 95 | 8 | MM14838 |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MTARC1 | 1.17e-04 | 220 | 95 | 8 | M10320 |
| Pathway | KEGG_GLYCEROLIPID_METABOLISM | 3.25e-04 | 49 | 95 | 4 | M15902 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_LIPID | 6.62e-04 | 6 | 95 | 2 | MM14738 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_LIPID | 9.23e-04 | 7 | 95 | 2 | M27069 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.47e-03 | 183 | 95 | 6 | M39588 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.57e-03 | 9 | 95 | 2 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.57e-03 | 9 | 95 | 2 | MM15313 | |
| Pubmed | 6.53e-18 | 7 | 125 | 7 | 26074487 | ||
| Pubmed | 5.21e-17 | 8 | 125 | 7 | 32093886 | ||
| Pubmed | 1.10e-08 | 8 | 125 | 4 | 10748067 | ||
| Pubmed | 1.10e-08 | 8 | 125 | 4 | 18719240 | ||
| Pubmed | 1.10e-08 | 8 | 125 | 4 | 20142249 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 19572376 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 8333863 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 29138287 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 7835904 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 28882566 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 23223495 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 7.70e-08 | 12 | 125 | 4 | 20308471 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 10024527 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 26176234 | ||
| Pubmed | NRDE2 FLNB FAM234B EXOSC10 TCAF1 STARD8 DGKA DGKZ RICTOR GLB1L2 AP3M1 SEPTIN8 PHKB LTN1 SLC25A38 SLC33A1 NUP153 | 3.69e-07 | 1084 | 125 | 17 | 11544199 | |
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 27499200 | ||
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 15318931 | ||
| Pubmed | A role for SHPS-1/SIRPalpha1 in IL-1beta- and TNFalpha-dependent signaling. | 8.99e-07 | 6 | 125 | 3 | 12483539 | |
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 20056642 | ||
| Pubmed | 2.50e-06 | 8 | 125 | 3 | 22579593 | ||
| Pubmed | 4.15e-06 | 66 | 125 | 5 | 19898482 | ||
| Pubmed | 4.45e-06 | 257 | 125 | 8 | 16335952 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | RPL24 EXOSC10 ARID4B TUBGCP2 AP3M1 PHKB FRY TENM4 HERC2 KCNT1 | 8.99e-06 | 475 | 125 | 10 | 31040226 |
| Pubmed | 9.74e-06 | 12 | 125 | 3 | 18161889 | ||
| Pubmed | A pathway sensor for genome-wide screens of intracellular proteolytic cleavage. | 9.74e-06 | 12 | 125 | 3 | 18387192 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24280043 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 10222050 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 32660355 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20876810 | ||
| Pubmed | Differential regulation of primary and memory CD8 T cell immune responses by diacylglycerol kinases. | 1.28e-05 | 2 | 125 | 2 | 22271650 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28962835 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 1909870 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24121496 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 27697466 | ||
| Pubmed | Synaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport. | 1.28e-05 | 2 | 125 | 2 | 19147495 | |
| Pubmed | Functional overlap between the mammalian Sar1a and Sar1b paralogs in vivo. | 1.28e-05 | 2 | 125 | 2 | 38687799 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17263731 | ||
| Pubmed | Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer. | 1.28e-05 | 2 | 125 | 2 | 36347965 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24267955 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22170718 | ||
| Pubmed | Glucuronidation of trans-3'-hydroxycotinine by UGT2B17 and UGT2B10. | 1.28e-05 | 2 | 125 | 2 | 22228205 | |
| Pubmed | Silencing of mammalian Sar1 isoforms reveals COPII-independent protein sorting and transport. | 1.28e-05 | 2 | 125 | 2 | 23433038 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24338480 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 15319348 | ||
| Pubmed | Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5. | 1.28e-05 | 2 | 125 | 2 | 3105095 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17848572 | ||
| Pubmed | Modulation of membrane rigidity by the human vesicle trafficking proteins Sar1A and Sar1B. | 1.28e-05 | 2 | 125 | 2 | 22974979 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28438506 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 27496708 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17698910 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24599142 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 31710099 | ||
| Pubmed | Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases. | 1.28e-05 | 2 | 125 | 2 | 23576561 | |
| Pubmed | Diacylglycerol Kinase ζ Is a Target To Enhance NK Cell Function. | 1.28e-05 | 2 | 125 | 2 | 27342844 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 30689197 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17687269 | ||
| Pubmed | Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation. | 1.28e-05 | 2 | 125 | 2 | 3117546 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18689679 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17604277 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21679149 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25921290 | ||
| Pubmed | Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. | 1.28e-05 | 2 | 125 | 2 | 17028587 | |
| Pubmed | Molecular analysis of SAR1-related cDNAs from a mouse pituitary cell line. | 1.28e-05 | 2 | 125 | 2 | 8262187 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28228532 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 34290409 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 15666817 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | STRN3 PSEN1 TOR1A XPO4 SLC6A15 TUBGCP2 AASS LTN1 UGGT2 HERC2 NUP153 MTARC1 | 1.86e-05 | 754 | 125 | 12 | 33060197 |
| Pubmed | No replication of genetic association between candidate polymorphisms and Alzheimer's disease. | 2.45e-05 | 16 | 125 | 3 | 19889475 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HSPG2 FAM234B FRAS1 ABCF1 TOR1A SLC6A15 GLB1L2 CHRNA5 VKORC1L1 ASPH LTN1 UGGT2 IL1RAP SLC33A1 MTARC1 | 2.83e-05 | 1201 | 125 | 15 | 35696571 |
| Pubmed | 3.56e-05 | 18 | 125 | 3 | 20056724 | ||
| Pubmed | 3.56e-05 | 18 | 125 | 3 | 20602751 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 36202053 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 15034021 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 34917090 | ||
| Pubmed | Small GTPases SAR1A and SAR1B regulate the trafficking of the cardiac sodium channel Nav1.5. | 3.84e-05 | 3 | 125 | 2 | 30251687 | |
| Pubmed | Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha. | 3.84e-05 | 3 | 125 | 2 | 19667119 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 28669759 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 23943838 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 12134038 | ||
| Pubmed | Central nervous system antigen P84 can serve as a substrate for neurite outgrowth. | 3.84e-05 | 3 | 125 | 2 | 2303162 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 16141346 | ||
| Pubmed | A role for SHPS-1/SIRPalpha in Concanavalin A-dependent production of MMP-9. | 3.84e-05 | 3 | 125 | 2 | 17825046 | |
| Pubmed | SIRPα deficiency accelerates the pathologic process in models of Parkinson disease. | 3.84e-05 | 3 | 125 | 2 | 31322787 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 26385605 | ||
| Pubmed | The Rho kinase pathway regulates the migration of dendritic cells through SIRP-α. | 3.84e-05 | 3 | 125 | 2 | 22391241 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 23472187 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 25795378 | ||
| Pubmed | Deficiency in SIRP-α cytoplasmic recruitment confers protection from acute kidney injury. | 3.84e-05 | 3 | 125 | 2 | 31370677 | |
| Pubmed | A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression. | 3.84e-05 | 3 | 125 | 2 | 30770827 | |
| Pubmed | Signal regulatory protein α protects podocytes through promoting autophagic activity. | 3.84e-05 | 3 | 125 | 2 | 30888336 | |
| Pubmed | Podocyte SIRPα reduction aggravates lupus nephritis via promoting T cell inflammatory responses. | 3.84e-05 | 3 | 125 | 2 | 38758648 | |
| Pubmed | Requirement of SIRPα for protective immunity against Leishmania major. | 3.84e-05 | 3 | 125 | 2 | 20854790 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 9271230 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 10585853 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 18635660 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 25377878 | ||
| Pubmed | Resistance to collagen-induced arthritis in SHPS-1 mutant mice. | 3.84e-05 | 3 | 125 | 2 | 18455510 | |
| Pubmed | Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function. | 3.84e-05 | 3 | 125 | 2 | 19223164 | |
| Pubmed | Endothelial SIRPα signaling controls VE-cadherin endocytosis for thymic homing of progenitor cells. | 3.84e-05 | 3 | 125 | 2 | 35511221 | |
| Pubmed | Focal cerebral ischemia upregulates SHP-1 in reactive astrocytes in juvenile mice. | 3.84e-05 | 3 | 125 | 2 | 12742627 | |
| Interaction | UGT2B28 interactions | 4.17e-06 | 6 | 121 | 3 | int:UGT2B28 | |
| Interaction | UGT2B11 interactions | 7.26e-06 | 7 | 121 | 3 | int:UGT2B11 | |
| Cytoband | 4q13 | 6.98e-08 | 15 | 125 | 4 | 4q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 2.72e-07 | 157 | 125 | 7 | chr4q13 | |
| Cytoband | 4q13.2 | 8.38e-05 | 31 | 125 | 3 | 4q13.2 | |
| Cytoband | 14q32.11 | 9.74e-04 | 17 | 125 | 2 | 14q32.11 | |
| GeneFamily | UDP glucuronosyltransferases | 1.02e-10 | 32 | 83 | 7 | 363 | |
| GeneFamily | CD molecules|V-set domain containing|C1-set domain containing|Signal regulatory proteins | 2.06e-04 | 5 | 83 | 2 | 747 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 9.15e-04 | 10 | 83 | 2 | 1178 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 9.23e-04 | 163 | 83 | 5 | 590 | |
| GeneFamily | Immunoglobulin like domain containing | 1.95e-03 | 193 | 83 | 5 | 594 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 2.10e-03 | 15 | 83 | 2 | 696 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 2.40e-03 | 16 | 83 | 2 | 173 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.04e-03 | 18 | 83 | 2 | 91 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 4.53e-03 | 22 | 83 | 2 | 464 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | FRAS1 AASS UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 IL1RAP | 2.16e-08 | 190 | 122 | 10 | MM1311 |
| Coexpression | VANLOO_SP3_TARGETS_DN | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MTARC1 | 2.87e-08 | 103 | 122 | 8 | MM919 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP | RELN CEL SESN3 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 SRPK3 UGT2B28 UGT2B11 | 5.16e-08 | 267 | 122 | 11 | MM984 |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | PDZK1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 IL1RAP | 4.43e-07 | 201 | 122 | 9 | MM1294 |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 1.62e-06 | 121 | 122 | 7 | MM935 | |
| Coexpression | GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN | 4.57e-06 | 200 | 122 | 8 | M4373 | |
| Coexpression | WENG_POR_TARGETS_LIVER_UP | 4.83e-06 | 53 | 122 | 5 | MM1203 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 4.93e-06 | 143 | 122 | 7 | M1935 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 4.93e-06 | 143 | 122 | 7 | MM819 | |
| Coexpression | HOFFMAN_CLOCK_TARGETS_UP | 1.15e-05 | 10 | 122 | 3 | M2063 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | AASS UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 IL1RAP | 2.50e-05 | 330 | 122 | 9 | MM1120 |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | PDZK1 GRK3 AASS UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MTARC1 | 4.22e-05 | 535 | 122 | 11 | MM3635 |
| Coexpression | GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_UP | 4.33e-05 | 200 | 122 | 7 | M7752 | |
| Coexpression | BOCHKIS_FOXA2_TARGETS | AP3M1 AASS SAR1B UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 6.82e-05 | 467 | 122 | 10 | MM1233 |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 1.30e-04 | 166 | 122 | 6 | M2398 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRHDE OTOA FRAS1 RELN NRCAM SLC6A17 PKHD1L1 TENM4 PTPRQ CSMD1 | 1.21e-10 | 184 | 125 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRHDE OTOA FRAS1 RELN NRCAM SLC6A17 PKHD1L1 TENM4 PTPRQ CSMD1 | 1.21e-10 | 184 | 125 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRHDE OTOA FRAS1 RELN NRCAM SLC6A17 PKHD1L1 TENM4 PTPRQ CSMD1 | 1.21e-10 | 184 | 125 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-07 | 160 | 125 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-07 | 160 | 125 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.54e-07 | 171 | 125 | 7 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.54e-07 | 171 | 125 | 7 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 6.99e-07 | 177 | 125 | 7 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-06 | 159 | 125 | 6 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-06 | 159 | 125 | 6 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-06 | 165 | 125 | 6 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-06 | 165 | 125 | 6 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 7.52e-06 | 166 | 125 | 6 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.52e-06 | 166 | 125 | 6 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.52e-06 | 166 | 125 | 6 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.05e-06 | 168 | 125 | 6 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | LV-11._Adipocyte|LV / Chamber and Cluster_Paper | 9.52e-06 | 173 | 125 | 6 | c2d3fcb3de71015d03d14c63450853d2b03ffa71 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 1.12e-05 | 178 | 125 | 6 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 1.19e-05 | 180 | 125 | 6 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.31e-05 | 183 | 125 | 6 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 1.31e-05 | 183 | 125 | 6 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.48e-05 | 187 | 125 | 6 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-05 | 187 | 125 | 6 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-05 | 187 | 125 | 6 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-05 | 188 | 125 | 6 | 1f912ea015f50570e848259d948a0ba682d64bb4 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.53e-05 | 188 | 125 | 6 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | control-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.57e-05 | 189 | 125 | 6 | bdfd120900ba58d5e54765f7b576e1f8cc2401bf | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 189 | 125 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 189 | 125 | 6 | 98ace332c3c046694c6ade47de8c8bf57ec51271 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 189 | 125 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 191 | 125 | 6 | d78d4fbb0b8317dbf14e32182466a432abef3e93 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-05 | 191 | 125 | 6 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-05 | 192 | 125 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-05 | 192 | 125 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 194 | 125 | 6 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-05 | 194 | 125 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-05 | 194 | 125 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.82e-05 | 194 | 125 | 6 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 195 | 125 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-05 | 196 | 125 | 6 | 72b6a68ee760599ea86cd2d712bfd17b7b4ee417 | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX-Bronchial_vessel|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.04e-05 | 198 | 125 | 6 | dcf334d13e5b0018fee24febccfef91c9e17843b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-05 | 199 | 125 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.88e-05 | 141 | 125 | 5 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.88e-05 | 141 | 125 | 5 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 142 | 125 | 5 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.97e-05 | 152 | 125 | 5 | f717aae4882e9b67e5e40f4ef5b0d35f74a89165 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C|TCGA-Thymus / Sample_Type by Project: Shred V9 | 9.70e-05 | 163 | 125 | 5 | 2dac87d15051151ccf193760ddd8b82534c3f922 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.98e-05 | 164 | 125 | 5 | 43630a448f4369fa9e4e3eccdf3b9f29cec16c39 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.98e-05 | 164 | 125 | 5 | 108fbecb56d69a675d6ce6e826a873ae528f2fd7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.98e-05 | 164 | 125 | 5 | 46208f18325976c89f572f6627aea0582142b92d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 167 | 125 | 5 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 168 | 125 | 5 | b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 168 | 125 | 5 | 838ce47d4958ba12047882f97925eddd02f081c7 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.18e-04 | 170 | 125 | 5 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | Healthy/Control-NK_CD56bright|World / Disease group and Cell class | 1.21e-04 | 171 | 125 | 5 | 79d7efefdae267905af05f3001514b8b6934d86e | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 172 | 125 | 5 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 172 | 125 | 5 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 172 | 125 | 5 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | Healthy/Control-NK_CD56bright|Healthy/Control / Disease group and Cell class | 1.32e-04 | 174 | 125 | 5 | f53f675c8cb14294ac526dcc3dca4f08288f8473 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.35e-04 | 175 | 125 | 5 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 175 | 125 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 175 | 125 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 177 | 125 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 177 | 125 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 177 | 125 | 5 | 75cb2067a3f2d1b5a964890b02b604d1e79bd163 | |
| ToppCell | mild_COVID-19-NK_CD56bright|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.54e-04 | 180 | 125 | 5 | d8b418edd807a51c0b5f4018b8b478dcc65892a7 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-04 | 181 | 125 | 5 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-04 | 181 | 125 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-04 | 181 | 125 | 5 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 1.58e-04 | 181 | 125 | 5 | 56fa77ae31f3b7de6e441a439c33a11353b6573a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-04 | 181 | 125 | 5 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.67e-04 | 183 | 125 | 5 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | mild_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 1.67e-04 | 183 | 125 | 5 | 9a4899afac0f91203209392c5f67b3d0aa356b86 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 186 | 125 | 5 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.84e-04 | 187 | 125 | 5 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.84e-04 | 187 | 125 | 5 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 188 | 125 | 5 | 14e120b20e76baa07b6510a94f0c2dcdfdd52357 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.89e-04 | 188 | 125 | 5 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | Healthy_donor-NK_CD56bright|Healthy_donor / disease group, cell group and cell class (v2) | 1.94e-04 | 189 | 125 | 5 | 9eac380a3bb4b685effb52d816e1960972660646 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-04 | 189 | 125 | 5 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-04 | 189 | 125 | 5 | 0739baad9a7da511dd3d7249f84299aee88370a1 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 189 | 125 | 5 | 443359d90fafae0c1de6bdcce9e8c95df6ea4de8 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.94e-04 | 189 | 125 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-04 | 189 | 125 | 5 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.94e-04 | 189 | 125 | 5 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | droplet-Heart-nan-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 189 | 125 | 5 | 0493f7b79127c207fd7ade778ef4810500495d7e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.98e-04 | 190 | 125 | 5 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.98e-04 | 190 | 125 | 5 | 40d8b3403f4e38436b961cd3a2e69826cbae3042 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.98e-04 | 190 | 125 | 5 | f6cbf6d292f488ada5f7581e1dceba6198b933d1 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.98e-04 | 190 | 125 | 5 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.98e-04 | 190 | 125 | 5 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.98e-04 | 190 | 125 | 5 | a9a705455019e28d655636de73b07540798f82e6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.98e-04 | 190 | 125 | 5 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 190 | 125 | 5 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | 390C-Myeloid-Macrophage|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.98e-04 | 190 | 125 | 5 | f933d971f092c4e56e9f670a9205b688c8b1ca28 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-04 | 190 | 125 | 5 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-04 | 191 | 125 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.03e-04 | 191 | 125 | 5 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-04 | 192 | 125 | 5 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| Computational | Steroid hormone and heme metabolism. | 2.67e-06 | 16 | 69 | 4 | MODULE_505 | |
| Computational | Genes in the cancer module 227. | 1.09e-04 | 15 | 69 | 3 | MODULE_227 | |
| Drug | C1 11-32 | 2.70e-12 | 18 | 119 | 7 | CID000443077 | |
| Drug | C11131 | 2.70e-12 | 18 | 119 | 7 | CID000443076 | |
| Drug | T4-G | 4.26e-12 | 19 | 119 | 7 | CID000152424 | |
| Drug | estriol-16-glucuronide | 9.75e-12 | 21 | 119 | 7 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 2.04e-11 | 23 | 119 | 7 | CID000066651 | |
| Drug | L-idaro-1,4-lactone | 9.64e-11 | 28 | 119 | 7 | CID000078997 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.26e-10 | 29 | 119 | 7 | CID000125641 | |
| Drug | oxazepam | 3.20e-10 | 53 | 119 | 8 | CID000004616 | |
| Drug | AC1Q6OQG | 3.40e-10 | 33 | 119 | 7 | CID000009686 | |
| Drug | BP-3,6-quinol | 3.40e-10 | 33 | 119 | 7 | CID000119292 | |
| Drug | AC1NOWCJ | 5.31e-10 | 35 | 119 | 7 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 5.31e-10 | 35 | 119 | 7 | CID010436171 | |
| Drug | estrone-3-glucuronide | 5.31e-10 | 35 | 119 | 7 | CID000115255 | |
| Drug | SN-38G | 7.79e-10 | 59 | 119 | 8 | CID000443154 | |
| Drug | l-borneol | 8.06e-10 | 37 | 119 | 7 | CID000010049 | |
| Drug | harmol | 1.44e-09 | 40 | 119 | 7 | CID000068094 | |
| Drug | testosterone glucuronide | 1.73e-09 | 41 | 119 | 7 | CID000108192 | |
| Drug | 2-AF | 1.73e-09 | 41 | 119 | 7 | CID000005800 | |
| Drug | androsterone glucuronide | 2.46e-09 | 43 | 119 | 7 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 2.46e-09 | 43 | 119 | 7 | CID000009191 | |
| Drug | methoxyresorufin | ZSWIM2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 2.81e-09 | 69 | 119 | 8 | CID000119220 |
| Drug | MS-222 | 2.91e-09 | 44 | 119 | 7 | CID000011400 | |
| Drug | salicylamide | 5.50e-09 | 48 | 119 | 7 | CID000005147 | |
| Drug | benzyloxyresorufin | PTCHD3 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 7.59e-09 | 78 | 119 | 8 | CID000114982 |
| Drug | AC1NQGK1 | 9.82e-09 | 52 | 119 | 7 | CID005195977 | |
| Drug | 5 alpha-androstane | 1.37e-08 | 84 | 119 | 8 | CID000094144 | |
| Drug | menthol | 1.82e-08 | 87 | 119 | 8 | CID000001254 | |
| Drug | 7-methoxycoumarin | 1.90e-08 | 57 | 119 | 7 | CID000010748 | |
| Drug | phenolphthalein | 2.15e-08 | 58 | 119 | 7 | CID000004764 | |
| Drug | urochloralic acid | 2.43e-08 | 59 | 119 | 7 | CID003036914 | |
| Drug | 4-hydroxybiphenyl | 2.43e-08 | 59 | 119 | 7 | CID000007103 | |
| Drug | 4-hydroxyestrone | 2.43e-08 | 59 | 119 | 7 | CID000018418 | |
| Drug | acetaminophen glucuronide | 2.43e-08 | 59 | 119 | 7 | CID000083944 | |
| Drug | UDP-alpha-d-xylopyranose | 2.74e-08 | 60 | 119 | 7 | CID000001165 | |
| Drug | 3-OHBaP | 3.87e-08 | 63 | 119 | 7 | CID000025890 | |
| Drug | Meldola | 6.64e-08 | 68 | 119 | 7 | CID000081507 | |
| Drug | eugenol | 1.09e-07 | 73 | 119 | 7 | CID000003314 | |
| Drug | 2,2,2-trichloroethanol | 1.09e-07 | 73 | 119 | 7 | CID000008259 | |
| Drug | 7-hydroxycoumarin | 1.32e-07 | 75 | 119 | 7 | CID005281426 | |
| Drug | 16-epiestriol | 1.58e-07 | 77 | 119 | 7 | CID000003269 | |
| Drug | AC1N8H7N | 1.73e-07 | 78 | 119 | 7 | CID004318740 | |
| Drug | Hymecromone | 1.75e-07 | 25 | 119 | 5 | ctd:D006923 | |
| Drug | fibrates | ARID4B UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.99e-07 | 118 | 119 | 8 | CID000002797 |
| Drug | acridine | 2.25e-07 | 81 | 119 | 7 | CID000009215 | |
| Drug | estrone-d4 | PDZK1 ACE UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 2.53e-07 | 168 | 119 | 9 | CID000000698 |
| Drug | 7-ethoxycoumarin | 3.41e-07 | 86 | 119 | 7 | CID000035703 | |
| Drug | hexobarbital | PTCHD3 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 3.51e-07 | 127 | 119 | 8 | CID000003608 |
| Drug | pentoxyresorufin | 3.69e-07 | 87 | 119 | 7 | CID000107683 | |
| Drug | 4-aminobiphenyl | 5.41e-07 | 92 | 119 | 7 | CID000007102 | |
| Drug | p-nitroanisole | 5.41e-07 | 92 | 119 | 7 | CID000007485 | |
| Drug | 2-naphthol | 5.83e-07 | 93 | 119 | 7 | CID000008663 | |
| Drug | NNAL | 6.45e-07 | 32 | 119 | 5 | CID000104856 | |
| Drug | ethoxyresorufin | 6.74e-07 | 95 | 119 | 7 | CID000003294 | |
| Drug | DCNB | 6.74e-07 | 95 | 119 | 7 | CID000007443 | |
| Drug | DB04103 | 7.77e-07 | 97 | 119 | 7 | CID004469987 | |
| Drug | 1-naphthol | 8.33e-07 | 98 | 119 | 7 | CID000007005 | |
| Drug | butylated hydroxytoluene | 8.67e-07 | 143 | 119 | 8 | CID000031404 | |
| Drug | anethole trithione | 9.57e-07 | 63 | 119 | 6 | CID000002194 | |
| Drug | 3-hydroxyandrostan-17-one | 1.09e-06 | 102 | 119 | 7 | CID000000225 | |
| Drug | phenolphthalin | 1.38e-06 | 5 | 119 | 3 | CID000066494 | |
| Drug | Amobarbital | 1.38e-06 | 5 | 119 | 3 | ctd:D000654 | |
| Drug | chrysin | 1.42e-06 | 106 | 119 | 7 | CID005281607 | |
| Drug | fluconazole | 1.51e-06 | 107 | 119 | 7 | CID000003365 | |
| Drug | 2-naphthylamine | 1.82e-06 | 110 | 119 | 7 | CID000007057 | |
| Drug | ethoxyquin | 2.60e-06 | 116 | 119 | 7 | CID000003293 | |
| Drug | lithocholic acid | 2.60e-06 | 116 | 119 | 7 | CID000009903 | |
| Drug | AC1Q7AUJ | 2.75e-06 | 117 | 119 | 7 | CID000003303 | |
| Drug | 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol | 2.75e-06 | 6 | 119 | 3 | ctd:C475721 | |
| Drug | 4-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid | 2.75e-06 | 6 | 119 | 3 | ctd:C099564 | |
| Drug | 2-hydroxyestriol | 2.75e-06 | 6 | 119 | 3 | CID000014688 | |
| Drug | lorcaserin | 2.75e-06 | 6 | 119 | 3 | ctd:C506658 | |
| Drug | alpha-naphthoflavone | 2.91e-06 | 118 | 119 | 7 | CID000011790 | |
| Drug | benzphetamine | 3.08e-06 | 119 | 119 | 7 | CID000002341 | |
| Drug | N'-nitrosoanatabine | 3.22e-06 | 20 | 119 | 4 | CID000051291 | |
| Drug | AC1L1OBF | 3.22e-06 | 20 | 119 | 4 | CID000032736 | |
| Drug | 3 -hydroxypregn-5-en-20-one | CEL GRK3 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 4.57e-06 | 238 | 119 | 9 | CID000001027 |
| Drug | ranirestat | 4.80e-06 | 7 | 119 | 3 | ctd:C115070 | |
| Drug | N'-nitrosoanabasine | 4.82e-06 | 22 | 119 | 4 | CID000014335 | |
| Drug | AC1L1FK5 | 5.27e-06 | 129 | 119 | 7 | CID000003272 | |
| Drug | 4-methylumbelliferone | 6.13e-06 | 132 | 119 | 7 | CID003364573 | |
| Drug | uridine 5'-diphosphoglucuronic acid | 6.95e-06 | 189 | 119 | 8 | CID000000390 | |
| Drug | propofol | 7.51e-06 | 191 | 119 | 8 | CID000004943 | |
| Drug | oltipraz | 7.83e-06 | 137 | 119 | 7 | CID000047318 | |
| Drug | aniline | 9.90e-06 | 142 | 119 | 7 | CID000006115 | |
| Drug | beta-naphthoflavone | ZSWIM2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.05e-05 | 200 | 119 | 8 | CID000002361 |
| Drug | chondroitin sulfate | HSPG2 PNLIP SEMA5A UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 B4GALNT3 UGT2B28 UGT2B11 | 1.12e-05 | 413 | 119 | 11 | CID000024766 |
| Drug | licochalcone A | 1.13e-05 | 27 | 119 | 4 | ctd:C070840 | |
| Drug | 2 E1 | 1.14e-05 | 145 | 119 | 7 | CID006102788 | |
| Drug | UDP-N-acetylglucosamine | 1.17e-05 | 203 | 119 | 8 | CID000001167 | |
| Drug | pheophytin | ARID4B CEL UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.88e-05 | 284 | 119 | 9 | CID000000250 |
| Drug | N'-nitrosonornicotine | 1.98e-05 | 63 | 119 | 5 | CID000027919 | |
| Drug | disulfiram | 1.98e-05 | 158 | 119 | 7 | CID000003117 | |
| Drug | 1,4-benzodiazepine | 2.23e-05 | 11 | 119 | 3 | CID000148431 | |
| Drug | AC1LCF1F | 2.24e-05 | 161 | 119 | 7 | CID000627275 | |
| Drug | R(-)-Denopamine | 2.58e-05 | 33 | 119 | 4 | CID000003818 | |
| Drug | al-Badry | 2.62e-05 | 165 | 119 | 7 | CID000004545 | |
| Drug | 2-hydroxyestriol | 2.71e-05 | 2 | 119 | 2 | ctd:C008012 | |
| Drug | buthionine sulfoximine | 2.79e-05 | 229 | 119 | 8 | CID000021157 | |
| Drug | 4-hydroxyestrone | 2.96e-05 | 12 | 119 | 3 | ctd:C026418 | |
| Drug | 3-methylcholanthrene | 2.97e-05 | 231 | 119 | 8 | CID000001674 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.38e-10 | 9 | 122 | 5 | EFO_0600040 | |
| Disease | X-19141 measurement | 1.39e-09 | 13 | 122 | 5 | EFO_0800799 | |
| Disease | deoxycholic acid glucuronide measurement | 1.92e-08 | 8 | 122 | 4 | EFO_0800575 | |
| Disease | X-24947 measurement | 2.77e-08 | 22 | 122 | 5 | EFO_0800910 | |
| Disease | cotinine measurement, trans-3-hydroxycotinine measurement | 1.37e-06 | 6 | 122 | 3 | EFO_0007813, EFO_0010707 | |
| Disease | vanillylmandelate (VMA) measurement | 2.38e-06 | 7 | 122 | 3 | EFO_0800119 | |
| Disease | X-12007 measurement | 1.70e-05 | 2 | 122 | 2 | EFO_0021276 | |
| Disease | level of tyrosine-protein phosphatase non-receptor type substrate 1 in blood serum | 1.70e-05 | 2 | 122 | 2 | OBA_2040362 | |
| Disease | serum clozapine-to-N-desmethylclozapine ratio measurement | 5.07e-05 | 3 | 122 | 2 | EFO_0600042 | |
| Disease | cholic acid glucuronide measurement | 5.07e-05 | 3 | 122 | 2 | EFO_0800574 | |
| Disease | phosphatidylcholine 36:4 measurement | 5.38e-05 | 18 | 122 | 3 | EFO_0010382 | |
| Disease | androsterone glucuronide measurement | 7.47e-05 | 20 | 122 | 3 | EFO_0800317 | |
| Disease | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement | 1.00e-04 | 22 | 122 | 3 | EFO_0005199, EFO_0005208, EFO_0007892 | |
| Disease | X-25937 measurement | 1.01e-04 | 4 | 122 | 2 | EFO_0800937 | |
| Disease | X-16576 measurement | 1.01e-04 | 4 | 122 | 2 | EFO_0800760 | |
| Disease | cotinine measurement | 1.15e-04 | 23 | 122 | 3 | EFO_0007813 | |
| Disease | cortolone glucuronide (1) measurement | 2.52e-04 | 6 | 122 | 2 | EFO_0800552 | |
| Disease | response to gemcitabine, response to antineoplastic agent | 2.52e-04 | 6 | 122 | 2 | GO_0036272, GO_0097327 | |
| Disease | alkaline phosphatase measurement | HSPG2 CEL MRS2 PHKB UGT2B4 UGT2B7 UGT2B15 UGT2B17 RP1 B4GALNT3 UGT2B11 SLC33A1 MTARC1 | 3.02e-04 | 1015 | 122 | 13 | EFO_0004533 |
| Disease | Lung diseases | 3.13e-04 | 78 | 122 | 4 | C0024115 | |
| Disease | X-24574 measurement | 3.51e-04 | 7 | 122 | 2 | EFO_0800897 | |
| Disease | X-24418 measurement | 3.51e-04 | 7 | 122 | 2 | EFO_0800879 | |
| Disease | serum N-desmethylclozapine measurement | 4.67e-04 | 8 | 122 | 2 | EFO_0600043 | |
| Disease | vitamin D deficiency | 4.84e-04 | 37 | 122 | 3 | EFO_0003762 | |
| Disease | urinary metabolite measurement | 5.58e-04 | 245 | 122 | 6 | EFO_0005116 | |
| Disease | time to first cigarette measurement | 5.99e-04 | 9 | 122 | 2 | EFO_0010126 | |
| Disease | signal-regulatory protein beta-1 measurement | 5.99e-04 | 9 | 122 | 2 | EFO_0802069 | |
| Disease | X-12844 measurement | 5.99e-04 | 9 | 122 | 2 | EFO_0021339 | |
| Disease | neuritic plaque measurement | 6.39e-04 | 349 | 122 | 7 | EFO_0006798 | |
| Disease | response to carboplatin, response to antineoplastic agent | 7.47e-04 | 10 | 122 | 2 | GO_0097327, GO_0097328 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 7.47e-04 | 10 | 122 | 2 | EFO_0022090 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 9.10e-04 | 11 | 122 | 2 | EFO_0801531 | |
| Disease | Epithelioid Cell Uveal Melanoma | 9.10e-04 | 11 | 122 | 2 | EFO_1000244 | |
| Disease | plasma N-desmethylclozapine measurement | 9.10e-04 | 11 | 122 | 2 | EFO_0600039 | |
| Disease | ficolin-3 measurement | 1.09e-03 | 12 | 122 | 2 | EFO_0020392 | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 1.09e-03 | 12 | 122 | 2 | C1861063 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.09e-03 | 12 | 122 | 2 | EFO_0800291 | |
| Disease | C-X-C motif chemokine 10 measurement | 1.11e-03 | 109 | 122 | 4 | EFO_0008056 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.16e-03 | 189 | 122 | 5 | EFO_0009932 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 1.17e-03 | 50 | 122 | 3 | EFO_0010732 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 1.28e-03 | 13 | 122 | 2 | EFO_0800293 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 1.49e-03 | 14 | 122 | 2 | EFO_0800283 | |
| Disease | optic cup area measurement | 1.63e-03 | 56 | 122 | 3 | EFO_0006940 | |
| Disease | lung small cell carcinoma (is_marker_for) | 1.96e-03 | 16 | 122 | 2 | DOID:5409 (is_marker_for) | |
| Disease | disease progression measurement | 2.08e-03 | 61 | 122 | 3 | EFO_0008336 | |
| Disease | metabolite measurement | 2.33e-03 | 560 | 122 | 8 | EFO_0004725 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 2.48e-03 | 18 | 122 | 2 | EFO_0800288 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 2.77e-03 | 19 | 122 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | cotinine glucuronidation measurement | 2.77e-03 | 19 | 122 | 2 | EFO_0006508 | |
| Disease | bipolar disorder (is_marker_for) | 2.77e-03 | 19 | 122 | 2 | DOID:3312 (is_marker_for) | |
| Disease | etiocholanolone glucuronide measurement | 2.77e-03 | 19 | 122 | 2 | EFO_0800362 | |
| Disease | diverticular disease | 3.05e-03 | 236 | 122 | 5 | EFO_0009959 | |
| Disease | Manic Disorder | 3.21e-03 | 71 | 122 | 3 | C0024713 | |
| Disease | rosacea severity measurement | 3.30e-03 | 147 | 122 | 4 | EFO_0009180 | |
| Disease | lung cancer (is_implicated_in) | 3.61e-03 | 74 | 122 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | Bronchiectasis | 3.71e-03 | 22 | 122 | 2 | C0006267 | |
| Disease | Amphetamine-Related Disorders | 3.75e-03 | 75 | 122 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 3.75e-03 | 75 | 122 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 3.75e-03 | 75 | 122 | 3 | C0236804 | |
| Disease | lung carcinoma | 3.98e-03 | 482 | 122 | 7 | EFO_0001071 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLQNNSYLWQIPLTI | 631 | Q9UKU6 | |
| SYLWQIPLTIVVGNR | 636 | Q9UKU6 | |
| NFGRRKSWLVPTQYI | 136 | O00400 | |
| VWKQVYQDLGIPVLN | 361 | Q4LE39 | |
| RVYQLFPSKGWQVHI | 546 | Q6ZRH7 | |
| LFQGYQKWVRPVLHS | 36 | Q05901 | |
| NNYLQGWRKTLLIVS | 491 | Q8NE71 | |
| KINKIRWLPQQNAAY | 91 | Q00005 | |
| KNNVTLSPNNGYWVL | 366 | Q6UXE8 | |
| LKLGNPFLTQWQRRY | 566 | P35626 | |
| PYGNNLNCIWKIIVT | 1821 | Q96PZ7 | |
| AQPLLKYFQPVTQWL | 596 | P12821 | |
| PRKTQWLNQVESYIA | 556 | Q6L9W6 | |
| NLLQWVPKYAGVSPR | 606 | Q9UP79 | |
| NPFLTQWVIYAIRNL | 411 | Q9UBB4 | |
| KRLNLQPLAYLWQRN | 131 | Q7L8W6 | |
| LINGIYWEQNTPRLL | 306 | Q9UDR5 | |
| YRNIVNLLTEKAPWN | 286 | Q9NP58 | |
| YWLLKRQARNGVPLI | 506 | Q9ULD4 | |
| QRSLYNVNGLKAQPW | 561 | Q12797 | |
| QLSNIPWRRAGVKYT | 161 | Q9Y2T2 | |
| LYLNIWVPQGRKQVS | 101 | P19835 | |
| NVVRNKQWLYPLGVS | 21 | A0A0D9SF12 | |
| QWYGPNTVAQVLKKL | 141 | Q9Y4P1 | |
| QPQAIITWYKRGGSL | 2656 | P98160 | |
| GVQTWTQPRLCYLVK | 126 | Q5T2W1 | |
| NPAVQFLYQKLIGWL | 656 | O94822 | |
| VRLKLLGQYGLPQHW | 741 | Q7RTW8 | |
| WYLQKPGQSPQLLIY | 61 | P01614 | |
| ILYGRVLWNPEQNLN | 3696 | Q86XX4 | |
| LLQQVGTVAQLWIYP | 51 | Q5VT66 | |
| NPLKVGYIRIWGVNT | 1746 | Q2M2H8 | |
| SNYVVKGNARLPVKW | 821 | P10721 | |
| RVKAAPYWITAPQNL | 356 | Q92823 | |
| QSLQGDLNPLWYKLR | 546 | Q9NVR5 | |
| KFIWYNNVINPTLPR | 416 | P16233 | |
| NNKPINVLTGIDYWL | 341 | Q3B7T1 | |
| WLKQNVQGLYPQSPL | 1621 | O95714 | |
| SKYPQGRFWKQLQVA | 531 | Q9NPH3 | |
| LTTYNPRKVQKLWNL | 441 | A6NM62 | |
| KNQPYKLGRQWPELL | 91 | Q9BZ68 | |
| EYTLQLSGPKNLTWQ | 156 | Q99665 | |
| LQIPLWSQRVIYLQG | 401 | Q5JUK3 | |
| PKQRLLGWIQNKIPY | 141 | O75369 | |
| LGWIQNKIPYLPITN | 146 | O75369 | |
| LSNPTKPLQLYRQWT | 621 | Q08499 | |
| QKWIPASQLREQLSY | 81 | Q9H8E8 | |
| QSLVLLRGQNLTPYW | 406 | A2RU67 | |
| LKLYPGNQVLWRSYV | 991 | Q9H7Z3 | |
| QRVLWKFQYILNPRQ | 391 | P23743 | |
| ALLQYWINTLQGKLS | 191 | Q9HD23 | |
| WLVAQQPALIHGYRK | 186 | Q8IW45 | |
| ISNYLAWFQQKPGKV | 51 | A0A075B6S4 | |
| QGLLSLQKLWFYIQP | 316 | Q9BSJ2 | |
| QLLANLWGPQKTISY | 81 | Q8N628 | |
| QSNPIYRLKRSWGAV | 351 | Q3MIN7 | |
| VRIPNKPNYSLNLWS | 511 | Q969R2 | |
| IGTILKWPNVNLRNY | 551 | Q6R327 | |
| RLYSLPQQVGAKAWI | 11 | Q9Y3Q4 | |
| RFQNWKRITVYLPLS | 1721 | P78509 | |
| SAVKLIWYLPRQPNG | 211 | Q9UMZ3 | |
| RPNVYWINKTDNSLL | 166 | O75144 | |
| VPGLQCVKYIQGLQW | 391 | P51843 | |
| NKQYQLADWRIRPLP | 416 | Q01780 | |
| IYKWANILIPVHIGN | 451 | P30532 | |
| IQKNLRQLNYVWIGL | 161 | Q9NZS2 | |
| IALPNNWQRYPRTKV | 261 | Q8WZ55 | |
| PPRQLNYIQVELKGW | 411 | O43559 | |
| GQNLNRIPYKDTFWK | 156 | Q13418 | |
| WYLQKPGQSPQLLIY | 61 | A0A087WW87 | |
| QNLGRYWNIGPQKTL | 581 | Q8IW92 | |
| LLQNTLWPEVQKLYG | 551 | Q6IA86 | |
| NVLVPVSWKRPQYSQ | 2376 | Q5TBA9 | |
| KIIQSFLWYLNPRQV | 311 | Q13574 | |
| LQIWLRQAQGKAPDY | 291 | Q96IW7 | |
| WFQQKPGQAPRTLIY | 56 | A0A075B6I9 | |
| PQYRAILWRKTGTQK | 136 | Q5VVW2 | |
| NPILYAWQVNKTLNL | 266 | Q3KNS1 | |
| IQIWPQQELVKAYLQ | 526 | Q93100 | |
| IQSWLQNINPYPTLK | 916 | P56715 | |
| TWKQGRQLLRQYLQE | 171 | Q13033 | |
| RPAWNSKLQYILAQV | 61 | Q9H2J7 | |
| ISIHWKGPLRLQQAY | 211 | P49768 | |
| YRNIWKNLLILGFTN | 301 | Q8WUG5 | |
| ELNWGRLNYIQIKRI | 686 | Q8NDG6 | |
| VRIYLSKGPNVKNWN | 811 | Q9Y4C2 | |
| PRLVSLQNLYLQWNK | 226 | Q86VH5 | |
| LQNLYLQWNKISVIG | 231 | Q86VH5 | |
| RKFYPQRLQLTWLEN | 276 | P78324 | |
| VLQRILAQQGWLGLY | 326 | Q8N5S1 | |
| QLNRYLTRWAPGSVK | 146 | Q9NVS2 | |
| WKNYLPAINGIVFLV | 86 | Q9NR31 | |
| GKLYAWAVQNIRNVL | 461 | Q9BVR0 | |
| QLNLWDYVLSPQQVK | 1576 | Q4LDE5 | |
| QIYQLLPKDQWLAAA | 666 | Q92502 | |
| QLYPLKFQWIGQAVT | 246 | Q96DW6 | |
| LPPLRTAQYNSKWLN | 201 | Q13591 | |
| KFYPQRLQLTWLENG | 276 | Q5TFQ8 | |
| LLKWIIKSNYQGLPV | 171 | Q9UPE1 | |
| QPRQDYQLGFTLIWK | 176 | Q13155 | |
| LLPKYQKLNTWNGDL | 6 | Q8IUQ0 | |
| QKTQGIWLSPLYPRI | 291 | Q9NUW8 | |
| QWIIGYLLQKVISNL | 676 | Q9C0E2 | |
| LYKDQLQLWIRGNVS | 146 | O14656 | |
| LVLLRDNGLQYWKQL | 386 | Q8N427 | |
| DNGLQYWKQLLGPRT | 391 | Q8N427 | |
| LSKRNPRQINWTVLY | 41 | P83731 | |
| ASQGYLWNLQVKLEP | 351 | Q96DM3 | |
| TLGLNTRLYKWIPQN | 346 | P06133 | |
| WLNGLEYVPQRLKNL | 141 | P58005 | |
| QLQTVSINDKPLWRY | 2201 | Q6N022 | |
| VKVGNKLVRARQYPW | 246 | Q92599 | |
| LIALSVWPGTYQNRK | 3386 | Q86WI1 | |
| LQGYTQVLVKWLVQR | 46 | Q9Y279 | |
| SVKNIVPGWLQRYFN | 46 | P49790 | |
| ILKQWNATGCQPVRY | 261 | O43548 | |
| ALGLNTRLYKWIPQN | 346 | O75310 | |
| VYLNEAWKRQLQPKQ | 161 | Q8N0U8 | |
| GQVIYNPLTWKNSAV | 386 | Q8NEG5 | |
| LGLNTRLYKWIPQND | 346 | P36537 | |
| PAWNSKLQYILAQIG | 61 | Q9H1V8 | |
| NTLGSNTRLYKWLPQ | 346 | P54855 | |
| NTRLYKWLPQNDLLG | 351 | P54855 | |
| YFQLKANPGAWILRL | 1131 | Q9NYU1 | |
| ALGLNTRLYKWIPQN | 346 | Q9BY64 | |
| TLGLNTRLYKWIPQN | 346 | P16662 | |
| WKNYLPAINGIVFLV | 86 | Q9Y6B6 | |
| WQYLSGGKVKLQQNP | 121 | Q9BXI6 | |
| NTLGSNTRLYKWLPQ | 346 | O75795 | |
| NTRLYKWLPQNDLLG | 351 | O75795 | |
| NYRNLVWLGLSISKP | 46 | Q8NB42 |